Sacheerome Earnings Call Transcript: Key Takeaways
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
H1 FY27: total income ₹8,592L (+9.84% YoY), EBITDA ₹2,369L (+12.27%), PAT ₹1,679L (+12.38%), EBITDA margin 27.57%. YEIDA trial production began Sep 2026.
Sacheerome Limited reported record FY26 results with Revenue of ₹152.39cr and 26.02% EBITDA margin. Strategy focuses on a 4x capacity expansion via the new YEIDA facility.
Sacheerome Limited delivered robust H2 FY26 performance with Revenue at ₹7,582 Lakhs and PAT at ₹1,350 Lakhs, driven by its dual fragrance and flavour segments and B2B FMCG focus.